Back to Journals » Oncolytic Virotherapy » Volume 4

Mechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapy

Authors Simovic B, Walsh S, Wan Y

Received 24 May 2015

Accepted for publication 18 June 2015

Published 15 October 2015 Volume 2015:4 Pages 157—167

DOI https://doi.org/10.2147/OV.S66079

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Ahmed Majeed Al-Shammari

Peer reviewer comments 2

Editor who approved publication: Dr Faris Farassati


Boris Simovic, Scott R Walsh, Yonghong Wan

Department of Pathology and Molecular Medicine, McMaster Immunology Research Centre, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada

Abstract: Immunotherapy and oncolytic virotherapy have both shown anticancer efficacy in the clinic as monotherapies but the greatest promise lies in therapies that combine these approaches. Vesicular stomatitis virus is a prominent oncolytic virus with several features that promise synergy between oncolytic virotherapy and immunotherapy. This review will address the cytotoxicity of vesicular stomatitis virus in transformed cells and what this means for antitumor immunity and the virus' immunogenicity, as well as how it facilitates the breaking of tolerance within the tumor, and finally, we will outline how these features can be incorporated into the rational design of new treatment strategies in combination with immunotherapy.

Keywords: virotherapy, rhabdovirus, anti-tumor immunity, t cell, natural killer cell, therapeutic vaccine

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]